A staggering 16 novel agents have user fee goal dates in the next month, carrying the potential to transform US FDA’s approval narrative for 2023.
The pending novel agents outweigh the number of other user fee goal dates coming up in May, which include four...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?